Free Access
Issue |
J Extra Corpor Technol
Volume 45, Number 4, December 2013
|
|
---|---|---|
Page(s) | 235 - 241 | |
DOI | https://doi.org/10.1051/ject/201345235 | |
Published online | 15 December 2013 |
- Bull BS, Huse WM, Brauer FS. Heparin therapy during extracorporeal circulation: II. The use of a dose–response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685–689. [CrossRef] [Google Scholar]
- Hattersley PG. Activated coagulation time of whole blood. JAMA. 1966;196:436–440. [CrossRef] [PubMed] [Google Scholar]
- Jerez R, Martín L, Lozano M. Anticoagulación durante la circulación extracorpórea: control y reversión. In: Gomar C, Mata MT, Pomar JL. (eds.) Fisiopatología y técnicas de circulación extracorpórea. Barcelona, Spain: Ergon; 2012:307–323. [Google Scholar]
- Weitkemper HH, Troitzsch D, Koerfer R. Realización práctica de la circulación extracorpórea. Tschaut RJ. Circulación extracorpórea en teoría y práctica. Lengerich. Germany: Pabst Science Publishers; 2003:352–366. [Google Scholar]
- Jobes DR. Safety issues in heparin and protamine administration for extracorporeal circulation. J Cardiothorac Vasc Anesth. 1998;12(Suppl 1):17–20. [Google Scholar]
- Lobato RL, Despotis GJ, Levy JH, et al. Anticoagulation management during cardiopulmonary bypass: A survey of 54 North American institutions. J Thorac Cardiovasc Surg. 2010;139:1665–1666. [CrossRef] [Google Scholar]
- Bull MH, Huse WM, Bull BS. Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. Anesthesiology. 1975;43:346–353. [CrossRef] [PubMed] [Google Scholar]
- Bull BS, Korpman RA, Huse WM, et al. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg. 1975;69:674–684. [CrossRef] [Google Scholar]
- Akl BF, Vargas GM, Neal J, et al. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1980;79:97–102. [CrossRef] [Google Scholar]
- Berger RL, Ramaswamy K, Ryan TJ. Reduced protamine dosage for heparin neutralization in open heart operations. Circulation. 1968;37:II154–II157. [CrossRef] [PubMed] [Google Scholar]
- Guffin AV, Dunbar RW, Kaplan JA, et al. Successful use of a reduced dose of protamine after cardiopulmonary bypass. Anesth Analg. 1976;55:110–113. [Google Scholar]
- Jobes DR, Schaffer GW, Aitken GL. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg. 1995;110:36–45. [CrossRef] [Google Scholar]
- Runge M, Møller CH, Steinbrüchel DA. Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study. J Extra Corpor Technol. 2009;41:10–14 (abstract). [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Mochizuki T, Olson PJ, Szlam F, et al. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg. 1998;87:781–785. [CrossRef] [PubMed] [Google Scholar]
- Despotis GJ, Joist JH. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: An update. J Cardiothorac Vasc Anesth. 1999;13(Suppl 1):18–29. [CrossRef] [Google Scholar]
- Jaryno SA, Zucker ML, LaDuca FM. The Hemochron Response RxDx heparin and protamine dosing system. J Extra Corpor Technol. 2004;36:258–262 (abstract). [CrossRef] [EDP Sciences] [Google Scholar]
- Milas BL, Jobes DR, Gorman RC. Management of bleeding and coagulopathy after heart surgery. Semin Thorac Cardiovasc Surg. 2000;12:326–336. [CrossRef] [Google Scholar]
- Hensley FA, Martin DE, Gravlee GP. Anestesia Cardiaca. Madrid, Spain: Marbán; 2004:511. [Google Scholar]
- Charnaia MA, Morozov IuA, Gladysheva VG, et al. Comparison of two schemes of administering the Russian protamine sulfate after extracorporeal circulation in cardiosurgical patients. Anesteziol Reanimatol. 2006:31–33 (abstract). [Google Scholar]
- Charnaia MA, Klypa TV, Morozov IuA, et al. Impact of protamine sulfate on hemostasis system after operations with artificial circulation. Khirurgiia (Mosk). 2007:17–20 (abstract). [PubMed] [Google Scholar]
- Shore-Lesserson L, Reich DL, DePerio M. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients. Can J Anaesth. 1998;45:10–18. [CrossRef] [PubMed] [Google Scholar]
- Hall RI. Protamine dosing—The quandary continues. Can J Anaesth. 1998;45:1–5. [CrossRef] [PubMed] [Google Scholar]
- Khan NU, Wayne CK, Barker J, et al. The effects of protamine over-dose on coagulation parameters as measured by the thrombelastograph. Eur J Anaesthesiol. 2010;27:624–627. [CrossRef] [PubMed] [Google Scholar]
- Instructions for use of the Activated Cotting Time Cartridges: Medtronic HR-ACT. Minneapolis, MN: Medtronic Inc., 2007. [Google Scholar]
- Hill AG, Groom RC, Mario JA, et al. More precise heparin and protamine management during cardiopulmonary bypass. Proceedings of the American Academy of Cardiovascular Perfusion. 1990:12–16. [Google Scholar]
- Despotis GJ, Joist JH, Hogue CWJr, et al. More effective suppression of hemostasis system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost. 1996;67: 2–8. [Google Scholar]
- Bowie JE, Kemna GD. Automated management of heparin anticoagulation in cardiovascular surgery. Proceedings of the American Academy of Cardiovascular Perfusion. 1985;6:1–5. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.